WallStreetZenWallStreetZen

NASDAQ: MDWD
Mediwound Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for MDWD

Based on 1 analyst offering 12 month price targets for Mediwound Ltd

Min Forecast
$36.00+109.06%
Avg Forecast
$36.00+109.06%
Max Forecast
$36.00+109.06%

Should I buy or sell MDWD stock?

Based on 1 analyst offering ratings for Mediwound Ltd.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although MDWD's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates MDWD as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their MDWD stock forecasts and price targets.

MDWD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-21

1 of 1

Forecast return on equity

Is MDWD forecast to generate an efficient return?

Company
19.2%
Industry
66.83%
Market
179.76%
MDWD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MDWD forecast to generate an efficient return on assets?

Company
9.71%
Industry
31.7%
MDWD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MDWD earnings per share forecast

What is MDWD's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
-$2.47
Avg 2 year Forecast
-$2.24
Avg 3 year Forecast
-$1.93

MDWD revenue forecast

What is MDWD's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$26.7M+57.63%
Avg 2 year Forecast
$33.8M+99.32%
Avg 3 year Forecast
$66.0M+288.9%
MDWD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MDWD revenue growth forecast

How is MDWD forecast to perform vs Biotechnology companies and vs the US market?

Company
52.68%
Industry
37.61%
Market
13.54%
MDWD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MDWD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MDWD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MDWD$17.22$36.00+109.06%Buy
CBUS$4.05$15.00+270.37%Strong Buy
KROS$11.27$20.50+81.90%Buy
HUMA$1.19$13.67+1,048.49%Strong Buy
RNAC$8.26$34.00+311.62%Strong Buy
View Top Biotech Stocks

Mediwound Stock Forecast FAQ

Is Mediwound Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: MDWD) stock is to Buy MDWD stock.

Out of 1 analyst, 0 (0%) are recommending MDWD as a Strong Buy, 1 (100%) are recommending MDWD as a Buy, 0 (0%) are recommending MDWD as a Hold, 0 (0%) are recommending MDWD as a Sell, and 0 (0%) are recommending MDWD as a Strong Sell.

If you're new to stock investing, here's how to buy Mediwound stock.

What is MDWD's earnings growth forecast for 2026-2028?

(NASDAQ: MDWD) Mediwound's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.97%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 36.16%.

Mediwound's earnings in 2026 is -$23,879,000.On average, 8 Wall Street analysts forecast MDWD's earnings for 2026 to be -$31,660,460, with the lowest MDWD earnings forecast at -$40,251,024, and the highest MDWD earnings forecast at -$26,145,196. On average, 7 Wall Street analysts forecast MDWD's earnings for 2027 to be -$28,696,824, with the lowest MDWD earnings forecast at -$34,590,724, and the highest MDWD earnings forecast at -$20,889,203.

In 2028, MDWD is forecast to generate -$24,743,598 in earnings, with the lowest earnings forecast at -$25,156,890 and the highest earnings forecast at -$23,988,892.

What is MDWD's revenue growth forecast for 2026-2028?

(NASDAQ: MDWD) Mediwound's forecast annual revenue growth rate of 52.68% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.61%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.54%.

Mediwound's revenue in 2026 is $16,959,000.On average, 8 Wall Street analysts forecast MDWD's revenue for 2026 to be $343,122,011, with the lowest MDWD revenue forecast at $309,083,199, and the highest MDWD revenue forecast at $404,307,162. On average, 7 Wall Street analysts forecast MDWD's revenue for 2027 to be $433,853,673, with the lowest MDWD revenue forecast at $396,221,019, and the highest MDWD revenue forecast at $460,845,989.

In 2028, MDWD is forecast to generate $846,529,351 in revenue, with the lowest revenue forecast at $603,765,362 and the highest revenue forecast at $1,275,711,030.

What is MDWD's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: MDWD) forecast ROA is 9.71%, which is lower than the forecast US Biotechnology industry average of 31.7%.

What is MDWD's Price Target?

According to 1 Wall Street analyst that have issued a 1 year MDWD price target, the average MDWD price target is $36.00, with the highest MDWD stock price forecast at $36.00 and the lowest MDWD stock price forecast at $36.00.

The Wall Street analyst predicted that Mediwound's share price could reach $36.00 by Nov 21, 2026. The average Mediwound stock price prediction forecasts a potential upside of 109.06% from the current MDWD share price of $17.22.

What is MDWD's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: MDWD) Mediwound's current Earnings Per Share (EPS) is -$2.10. On average, analysts forecast that MDWD's EPS will be -$2.47 for 2026, with the lowest EPS forecast at -$3.14, and the highest EPS forecast at -$2.04. On average, analysts forecast that MDWD's EPS will be -$2.24 for 2027, with the lowest EPS forecast at -$2.70, and the highest EPS forecast at -$1.63. In 2028, MDWD's EPS is forecast to hit -$1.93 (min: -$1.96, max: -$1.87).

What is MDWD's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: MDWD) forecast ROE is 19.2%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.